Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes

	Tuberculosis
	The latest tuberculosis news from News Medical

	Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes A large retrospective cohort study found that GLP-1 receptor agonist use was associated with a lower risk of tuberculosis in people with type 2 diabetes compared with sulfonylureas, metformin, DPP-4 inhibitors, and SGLT2 inhibitors.

	TB preventive treatment delivers real-world gains for people with HIV Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.

			Researchers uncover hidden function of known tuberculosis bacterium gene The complete genome for the tuberculosis bacterium was sequenced and published in 1998. Since then, scientists have deciphered about two-thirds of TB's genes. Or have they?

			Research Reveals Supposedly Decoded Gene Has Hidden Cellular Function The complete genome for the tuberculosis bacterium was sequenced and published in 1998. Since then, scientists have deciphered about two-thirds of TB's genes. Or have they?

	Study Reveals Previously Unknown Mechanism of RNA Synthesis Shared Across Life Forms Scientists have long been fascinated by two promising classes of antibiotics that disable RNA polymerase (RNAP).

	Men’s higher TB burden linked to greater exposure Men are more likely than women to catch tuberculosis (TB), finds a new study led by UCL (University College London) researchers.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026